These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22091305)

  • 21. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
    Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
    Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran.
    Zahiri Z; Sharami SH; Milani F; Mohammadi F; Kazemnejad E; Ebrahimi H; Dalil Heirati SF
    Int J Fertil Steril; 2016; 9(4):490-6. PubMed ID: 26985336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran.
    Pourteymour Fard Tabrizi F; Alipoor B; Mehrzad Sadaghiani M; Ostadrahimi A; Malek Mahdavi A
    Int J Fertil Steril; 2013 Jan; 6(4):244-9. PubMed ID: 24520447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of metabolic syndrome in women with polycystic ovary syndrome.
    Ersan F; Arslan E; Esmer AÇ; Aydın S; Gedikbaşı A; Gedikbaşı A; Alkış I; Ark C
    J Turk Ger Gynecol Assoc; 2012; 13(3):178-83. PubMed ID: 24592034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients.
    Albu A; Radian S; Fica S; Barbu CG
    Endocrine; 2015 Mar; 48(2):696-704. PubMed ID: 25022659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
    Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
    Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A prospective study of PCOS women.
    Kar S
    J Hum Reprod Sci; 2013 Jul; 6(3):194-200. PubMed ID: 24347934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
    Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.
    Krentowska A; Łebkowska A; Jacewicz-Święcka M; Hryniewicka J; Leśniewska M; Adamska A; Kowalska I
    Endocrine; 2021 May; 72(2):400-410. PubMed ID: 33442790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values.
    Kim JJ; Hwang KR; Oh SH; Chae SJ; Yoon SH; Choi YM
    Fertil Steril; 2019 Nov; 112(5):959-966.e1. PubMed ID: 31542165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
    Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
    J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome.
    Krentowska A; Kowalska I
    Diabetes Metab Res Rev; 2022 Jan; 38(1):e3464. PubMed ID: 33988288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome.
    Mehrabian F; Jahanmardi R
    Int J Prev Med; 2017; 8():79. PubMed ID: 29114377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.
    Ni RM; Mo Y; Chen X; Zhong J; Liu W; Yang D
    Eur J Endocrinol; 2009 Sep; 161(3):411-8. PubMed ID: 19542239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.